121 related articles for article (PubMed ID: 12008527)
1. [News in the management of chronic neuropathic diabetic ulcer].
Meaume S
Soins; 2001 Jun; (656):12-3. PubMed ID: 12008527
[No Abstract] [Full Text] [Related]
2. [11-Clinical aspects: diabetic foot ulcers].
Meaume S
Soins; 2005 Mar; (693):19-21. PubMed ID: 15796472
[No Abstract] [Full Text] [Related]
3. [New developments in the treatment of diabetic foot ulcers].
Bakker K; Schaper NC
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):409-12. PubMed ID: 10719543
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor for foot ulcerations. An effective adjunct to good wound care.
Watts SA
Adv Nurse Pract; 2001 Sep; 9(9):60-3. PubMed ID: 12420484
[No Abstract] [Full Text] [Related]
5. Platelet-derived growth factor for diabetic ulcers.
Med Lett Drugs Ther; 1998 Jul; 40(1031):73-4. PubMed ID: 9698702
[No Abstract] [Full Text] [Related]
6. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.
White R; McIntosh C
J Wound Care; 2009 Aug; 18(8):335-41. PubMed ID: 19862873
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic ulcers: diabetes and wounds, part II. Differential diagnosis and treatment.
Worley CA
Dermatol Nurs; 2006 Apr; 18(2):163-4. PubMed ID: 16708679
[No Abstract] [Full Text] [Related]
8. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].
Fruhstorfer B
Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088
[No Abstract] [Full Text] [Related]
9. WHS guidelines update: Diabetic foot ulcer treatment guidelines.
Lavery LA; Davis KE; Berriman SJ; Braun L; Nichols A; Kim PJ; Margolis D; Peters EJ; Attinger C
Wound Repair Regen; 2016; 24(1):112-26. PubMed ID: 26663430
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
Sibbald RG; Torrance G; Hux M; Attard C; Milkovich N
Ostomy Wound Manage; 2003 Nov; 49(11):76-84. PubMed ID: 14652415
[TBL] [Abstract][Full Text] [Related]
11. Stepping up care for diabetic foot ulcers.
Sieggreen MY
Nursing; 2005 Oct; 35(10):36-41; quiz 41-2. PubMed ID: 16205268
[No Abstract] [Full Text] [Related]
12. [Diabetic neuropathy: danger to the foot].
Manus JM
Rev Infirm; 2000 Apr; (59 Suppl):10. PubMed ID: 11062656
[No Abstract] [Full Text] [Related]
13. Light therapy and advanced wound care for a neuropathic plantar ulcer on a Charcot foot.
Sutterfield R
J Wound Ostomy Continence Nurs; 2008; 35(1):113-5; discussion 116-7. PubMed ID: 18199948
[TBL] [Abstract][Full Text] [Related]
14. Diabetic neuropathy: pathophysiology and prevention of foot ulcers.
Zangaro GA; Hull MM
Clin Nurse Spec; 1999 Mar; 13(2):57-65; quiz 66-8. PubMed ID: 10382400
[TBL] [Abstract][Full Text] [Related]
15. Diabetic wound and lower extremity disorder management.
Schwartz RS
Home Care Provid; 1998 Apr; 3(2):87-91; quiz 92-4. PubMed ID: 9611520
[No Abstract] [Full Text] [Related]
16. Use of Regranex gel for diabetic foot ulcers.
Piascik P
J Am Pharm Assoc (Wash); 1998; 38(5):628-30. PubMed ID: 9782698
[No Abstract] [Full Text] [Related]
17. [Foot ulcers in the diabetic patient].
Richard JL
Soins; 2008; (722):42-5. PubMed ID: 18333346
[No Abstract] [Full Text] [Related]
18. Managing diabetic foot ulcers.
Fowler E; Vesely N; Pelfrey M; Jordan S; Amberry T
Home Healthc Nurse; 1999 Jun; 17(6):357-64; quiz 365. PubMed ID: 10562012
[TBL] [Abstract][Full Text] [Related]
19. Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?
Bhansali A; Venkatesh S; Dutta P; Dhillon MS; Das S; Agrawal A
Diabetes Res Clin Pract; 2009 Jan; 83(1):e13-6. PubMed ID: 19081156
[TBL] [Abstract][Full Text] [Related]
20. Managing venous and neuropathic ulcers.
Zulkowski K; Ratliff CR
Nursing; 2004 Aug; 34(8):68. PubMed ID: 15286517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
